1. Home
  2. HURC vs VTVT Comparison

HURC vs VTVT Comparison

Compare HURC & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hurco Companies Inc.

HURC

Hurco Companies Inc.

HOLD

Current Price

$22.13

Market Cap

143.0M

Sector

Industrials

ML Signal

HOLD

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

HOLD

Current Price

$33.50

Market Cap

129.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURC
VTVT
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.0M
129.7M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
HURC
VTVT
Price
$22.13
$33.50
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$53.00
AVG Volume (30 Days)
18.4K
61.8K
Earning Date
06-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
8.59
N/A
EPS
N/A
N/A
Revenue
$178,554,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.50
$18.97
52 Week High
$23.75
$44.00

Technical Indicators

Market Signals
Indicator
HURC
VTVT
Relative Strength Index (RSI) 47.42 53.39
Support Level $16.29 $29.44
Resistance Level $23.48 $34.91
Average True Range (ATR) 0.75 1.41
MACD -0.17 0.06
Stochastic Oscillator 39.34 73.08

Price Performance

Historical Comparison
HURC
VTVT

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: